Patent US3344410A successfully refreshed from Google Patents.
US5380716A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
Assignee: Glycomed Inc
•
Filing: 1992-12-28
•
Granted: 1995-01-10
•
Expires: 2012-12-28
Abstract
Abstract Highly sulfated oligosaccharides in the form of hexasaccharide and octasaccharide compounds which have antiproliferative activity with respect to smooth muscle cells are useful in treatment of conditions characterized by unwanted smooth muscle cell proliferation such as a result of trauma or disease states such as asthma, congestive heart failure and hypertension. The oligosaccharides have increased ability to inhibit the proliferation of smooth muscle cells and decreased ability to act as an anticoagulant as compared with commercial heparin and/or unseparated fragments of heparin.
Inventors
- 👤 H. Edward Conrad
- 👤 Peter Fugedi
- 👤 Brian K. Brandley
- 👤 Lun H. Lam
- 👤 Roger A. Laine
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 05:30
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/715; C; C07; C07H; C07H11/00; C07H13/00; C07H13/02; C07H13/04; C07H17/00; C07H17/02; C07H17/04; C07H3/00; C07H3/06; C08; C08B; C08B37/00; C08B37/006; C08B37/0063; C08B37/0075; C08B37/0078
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
197 words
A compound that inhibits the proliferation of smooth muscle cells to a greater extent than commercial heparin, and has a decreased ability to act as an anticoagulant as compared to commercial heparin, the compound having the following structural formula: ##STR14## wherein each of A, B, C, and D is independently H or SO 3 R and each R is independently H or a cation, with the proviso that at least two of A, B, C or D is --SO 3 R; noting that hydroxyl groups on the sugars have been omitted in Formulas I and I(a) for greater clarity and the * adjacent the carbon substituted with COOH indicates any possible stereochemistry in either I or I(a); R 1 and R 2 are each independently hydrogen or a unit having the following structure: ##STR15## wherein when a unit of Formula I(a) is connected at one end, the hydrogen at that end is not present; and each of E and F is independently hydrogen or SO 3 R and noting that the hydroxyl group on the 3-position on each sugar is present but has been omitted for greater clarity and further noting that the 3-position is not sulfated.
Claim 2
Dependent Claim
197 words
A compound that inhibits the proliferation of smooth muscle cells to a greater extent than commercial heparin, and has a decreased ability to act as an anticoagulant as compared to commercial heparin, the compound having the following structural formula: ##STR14## wherein each of A, B, C, and D is independently H or SO 3 R and each R is independently H or a cation, with the proviso that at least two of A, B, C or D is --SO 3 R; noting that hydroxyl groups on the sugars have been omitted in Formulas I and I(a) for greater clarity and the * adjacent the carbon substituted with COOH indicates any possible stereochemistry in either I or I(a); R 1 and R 2 are each independently hydrogen or a unit having the following structure: ##STR15## wherein when a unit of Formula I(a) is connected at one end, the hydrogen at that end is not present; and each of E and F is independently hydrogen or SO 3 R and noting that the hydroxyl group on the 3-position on each sugar is present but has been omitted for greater clarity and further noting that the 3-position is not sulfated.
Claim 3
Dependent Claim
19 words
The compound of claim 1, wherein at least three of A, B, C or D are --SO 3 R.
Claim 4
Dependent Claim
17 words
The compound of claim 2, wherein all of A, B, C and D are --SO 3 R.
Claim 5
Dependent Claim
31 words
The compound of claim 1, wherein R 1 and R 2 are H, and each R is H, ----Na + , K + , Ca 2+ or NH 4 + ----.
Claim 6
Dependent Claim
138 words
A hexasaccharide and octasaccharide compound that inhibits the proliferation of smooth muscle cells to a greater extent than commercial heparin, and has a decreased ability to act as an anticoagulant as compared to commercial heparin, the compound having the following structural formula: ##STR16## wherein n is 1 or 2 and each of A, B, C and D is independently H or SO 3 R, wherein each R is independently H or a cation, with the proviso that at least two of said A, B, C and D are SO 3 R; and wherein a hydroxyl group present on the 3 position of each sugar is present but has been omitted from the depiction; and noting that the 3-position is not sulfated; and wherein the asterisk on the carbons substituted with carboxyl indicates that the stereochemistry is not determined.
Claim 7
Dependent Claim
138 words
A hexasaccharide and octasaccharide compound that inhibits the proliferation of smooth muscle cells to a greater extent than commercial heparin, and has a decreased ability to act as an anticoagulant as compared to commercial heparin, the compound having the following structural formula: ##STR16## wherein n is 1 or 2 and each of A, B, C and D is independently H or SO 3 R, wherein each R is independently H or a cation, with the proviso that at least two of said A, B, C and D are SO 3 R; and wherein a hydroxyl group present on the 3 position of each sugar is present but has been omitted from the depiction; and noting that the 3-position is not sulfated; and wherein the asterisk on the carbons substituted with carboxyl indicates that the stereochemistry is not determined.
Claim 8
Dependent Claim
19 words
A compound of claim 5, wherein at least three of A, B, C or D are --SO 3 R.
Claim 9
Dependent Claim
19 words
A compound of claim 5, wherein at least four of A, B, C or D are --SO 3 R.
Claim 10
Dependent Claim
19 words
A compound of claim 5, wherein at least five of A, B, C or D are --SO 3 R.
Claim 11
Dependent Claim
17 words
A compound of claim 5, wherein all of A, B, C and D are --SO 3 R.
Claim 12
Dependent Claim
22 words
A compound of claim 5, wherein each R is H,----Na + , K + , Ca 2+ or NH 4 + ----.
Claim 13
Dependent Claim
138 words
A hexasaccharide and octasaccharide compound that inhibits the proliferation of smooth muscle cells to a greater extent than commercial heparin, and has a decreased ability to act as an anticoagulant as compared with commercial heparin the compound having the following structural formula: ##STR17## wherein n is 1 or 2 and each of A, B, C and D is independently H or SO 3 R, wherein each R is independently H or a cation, with the proviso that at least two of said A, B, C and D are SO 3 R; and wherein a hydroxyl group present on the 3 position of each sugar is present but has been omitted from the depiction and noting that the 3-position is not sulfated; and wherein the asterisk on the carbons substituted with carboxyl indicates that the stereochemistry is not determined.
Claim 14
Dependent Claim
138 words
A hexasaccharide and octasaccharide compound that inhibits the proliferation of smooth muscle cells to a greater extent than commercial heparin, and has a decreased ability to act as an anticoagulant as compared with commercial heparin the compound having the following structural formula: ##STR17## wherein n is 1 or 2 and each of A, B, C and D is independently H or SO 3 R, wherein each R is independently H or a cation, with the proviso that at least two of said A, B, C and D are SO 3 R; and wherein a hydroxyl group present on the 3 position of each sugar is present but has been omitted from the depiction and noting that the 3-position is not sulfated; and wherein the asterisk on the carbons substituted with carboxyl indicates that the stereochemistry is not determined.
Claim 15
Dependent Claim
19 words
A compound of claim 11, wherein at least three of A, B, C or D are --SO 3 R.
Claim 16
Dependent Claim
19 words
A compound of claim 11, wherein at least four of A, B, C or D are --SO 3 R.
Claim 17
Dependent Claim
19 words
A compound of claim 11, wherein at least five of A, B, C or D are --SO 3 R.
Claim 18
Dependent Claim
17 words
A compound of claim 11, wherein all of A, B, C and D are --SO 3 R.
Claim 19
Dependent Claim
23 words
A compound of claim 11, wherein each R is H, ----Na + , K + , Ca 2+ or NH 4 + ----.
Claim 20
Dependent Claim
76 words
A pharmaceutical composition that inhibits unwanted smooth muscle cell proliferation, comprising: a pharmaceutically effective amount of a heparin digest derivative in the form of oligosaccharide fragments selected from the group consisting of a hexasaccharide or octasaccharide compound of claim 5 or pharmaceutically acceptable salts thereof which fragments have an increased ability to inhibit smooth muscle cell proliferation and a decreased ability to act as an anticoagulant as compared with commercial heparin; and a pharmaceutically acceptable carrier.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-01-09 | 1998-07-11 | 1999-01-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-01-09 | 2002-07-11 | 2003-01-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-01-09 | 2006-07-11 | 2007-01-10 | $7700.00 | Window Closed / Lapsed |